{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:30:57Z","timestamp":1791513057958,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["19 A1002"],"award-info":[{"award-number":["19 A1002"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ijid.2021.07.030","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T12:34:05Z","timestamp":1626266045000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Long-term weight gain after initiating combination antiretroviral therapy in treatment-na\u00efve Asian people living with human immunodeficiency virus"],"prefix":"10.1016","volume":"110","author":[{"given":"Naokatsu","family":"Ando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nishijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Gatanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2021.07.030_bib0001","unstructured":"Anonymous. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. 2021. Available at: https:\/\/clinicalinfo.hiv.gov\/en (last accessed 2 July 2021)."},{"key":"10.1016\/j.ijid.2021.07.030_bib0002","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/QAI.0000000000001699","article-title":"Pharmacokinetics of tenofovir alafenamide when coadministered with other HIV antiretrovirals","volume":"78","author":"Begley","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2021.07.030_bib0003","doi-asserted-by":"crossref","first-page":"e25484","DOI":"10.1002\/jia2.25484","article-title":"Weight gain among treatment-naive persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada","volume":"23","author":"Bourgi","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.ijid.2021.07.030_bib0004","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/cid\/ciz407","article-title":"Greater weight gain in treatment-naive persons starting dolutegravir-based antiretroviral therapy","volume":"70","author":"Bourgi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.07.030_bib0005","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/QAD.0b013e32832bd7af","article-title":"Veterans Aging Cohort Study. HIV infection and the risk of diabetes mellitus","volume":"23","author":"Butt","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2021.07.030_bib0006","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s15010-019-01376-5","article-title":"Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir\/ritonavir","volume":"48","author":"Calza","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2021.07.030_bib0007","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/QAD.0b013e32834e8776","article-title":"ANRS CO8 APROCO-COPILOTE Cohort Study Group. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment","volume":"26","author":"Capeau","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2021.07.030_bib0008","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s15010-018-1227-0","article-title":"A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015\u20132017","volume":"47","author":"Gomez","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2021.07.030_bib0009","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/QAI.0000000000001071","article-title":"Weight gain and incident diabetes among HIV-infected veterans initiating antiretroviral therapy compared with uninfected individuals","volume":"73","author":"Herrin","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl. 3","key":"10.1016\/j.ijid.2021.07.030_bib0010","doi-asserted-by":"crossref","first-page":"19583","DOI":"10.7448\/IAS.17.4.19583","article-title":"Should the dose of tenofovir be reduced to 200\u2013250 mg\/day, when combined with protease inhibitors?","volume":"17","author":"Hill","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.ijid.2021.07.030_bib0011","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/QAI.0000000000002650","article-title":"Impact of efavirenz mid-dose plasma concentration on long-term weight change among virologically suppressed people living with HIV","volume":"87","author":"Huang","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2021.07.030_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174360","article-title":"The HIV care cascade: Japanese perspectives","volume":"12","author":"Iwamoto","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2021.07.030_bib0013","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/hiv.13061","article-title":"Outcomes associated with treatment change from tenofovir disoproxil fumarate to tenofovir alafenamide in HIV-1-infected patients: a real-world study in Japan","volume":"22","author":"Kanda","year":"2021","journal-title":"HIV Med"},{"key":"10.1016\/j.ijid.2021.07.030_bib0014","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/aid.2015.0147","article-title":"Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada","volume":"32","author":"Koethe","year":"2016","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.ijid.2021.07.030_bib0015","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fendo.2018.00705","article-title":"The impact of weight gain during HIV treatment on risk of pre-diabetes, diabetes mellitus, cardiovascular disease, and mortality","volume":"9","author":"Kumar","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ijid.2021.07.030_bib0016","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijid.2019.12.029","article-title":"Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir\/cobicistat\/emtricitabine\/tenofovir alafenamide","volume":"92","author":"Kuo","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2021.07.030_bib0017","doi-asserted-by":"crossref","first-page":"e25702","DOI":"10.1002\/jia2.25702","article-title":"Weight gain before and after switch from TDF to TAF in a U.S. cohort study","volume":"24","author":"Mallon","year":"2021","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.ijid.2021.07.030_bib0018","first-page":"9","article-title":"Pathogenesis, clinical course, and recent issues in HIV-1-infected Japanese hemophiliacs: a three-decade follow-up","volume":"2","author":"Oka","year":"2020","journal-title":"Health Med"},{"key":"10.1016\/j.ijid.2021.07.030_bib0019","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1016\/S2352-3018(20)30099-0","article-title":"Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials","volume":"7","author":"Orkin","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ijid.2021.07.030_bib0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/hiv.12878","article-title":"2019 Update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0","volume":"21","author":"Ryom","year":"2020","journal-title":"HIV Med"},{"key":"10.1016\/j.ijid.2021.07.030_bib0021","doi-asserted-by":"crossref","first-page":"e81355","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2021.07.030_bib0022","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/QAI.0000000000000458","article-title":"Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation","volume":"68","author":"Sattler","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2021.07.030_bib0023","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/cid\/ciz999","article-title":"Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials","volume":"71","author":"Sax","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.07.030_bib0024","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx239","article-title":"Weight gain: a possible side effect of all antiretrovirals","volume":"4","author":"Taramasso","year":"2017","journal-title":"Open Forum Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221005750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221005750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:00:19Z","timestamp":1761120019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221005750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":24,"alternative-id":["S1201971221005750"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.07.030","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term weight gain after initiating combination antiretroviral therapy in treatment-na\u00efve Asian people living with human immunodeficiency virus","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}